Anti-Inflammatory Activity of Babassu Oil and Development of a Microemulsion System for Topical Delivery

• Published in: Evidence-based complementary and alternative medicine Vol. 2017; no. 2017; pp. 1 - 14
• Main Authors: Bianchi, Otávio, Melo, Janaína V., Mattos, Alessandra B., Ximenes, Rafael Matos, Machado, Giovanna, Saraiva, Karina L. A., Hallwass, Fernando, Santos, Geanne K. N., Navarro, Daniela M. A. Ferraz, Correia, Maria Tereza dos Santos, Silva, Márcia Vanusa da, Silva, Danielle R., Santos, Simone Maria dos, Reis, Mysrayn Y. F. A., da Silva, Alexandre Gomes
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01-01-2017; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Anti-inflammatory drugs; Arachidonic acid; Babassu oil; Edema; Herbal medicine; Inflammation; Lauric acid; Microemulsions; Oils & fats; Pharmaceutical sciences; Propylene; Rheological properties; Rheology; Saturated fatty acids; Surface active agents; Surfactants; Vegetable oils; Brazil; Canada
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2017/3647801

Babassu oil extraction is the main income source in nut breakers communities in northeast of Brazil. Among these communities, babassu oil is used for cooking but also medically to treat skin wounds and inflammation, and vulvovaginitis. This study aimed to evaluate the anti-inflammatory activity of babassu oil and develop a microemulsion system with babassu oil for topical delivery. Topical anti-inflammatory activity was evaluated in mice ear edema using PMA, arachidonic acid, ethyl phenylpropiolate, phenol, and capsaicin as phlogistic agents. A microemulsion system was successfully developed using a Span® 80/Kolliphor® EL ratio of 6 : 4 as the surfactant system (S), propylene glycol and water (3 : 1) as the aqueous phase (A), and babassu oil as the oil phase (O), and analyzed through conductivity, SAXS, DSC, TEM, and rheological assays. Babassu oil and lauric acid showed anti-inflammatory activity in mice ear edema, through inhibition of eicosanoid pathway and bioactive amines. The developed formulation (39% A, 12.2% O, and 48.8% S) was classified as a bicontinuous to o/w transition microemulsion that showed a Newtonian profile. The topical anti-inflammatory activity of microemulsified babassu oil was markedly increased. A new delivery system of babassu microemulsion droplet clusters was designed to enhance the therapeutic efficacy of vegetable oil.